Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term

ClinicalTrials.gov ID: NCT02697916

Public ClinicalTrials.gov record NCT02697916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 9:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ADAPTABLE is a pragmatic clinical trial in which 15,000 patients who are at high risk for ischemic events will be randomly assigned in a 1:1 ratio to receive an aspirin dose of 81 mg/day vs. 325 mg/day. Study participants will be enrolled over 38 months. Maximum follow-up will be 50 months. The purpose of the study is to identify the optimal dose of aspirin for secondary prevention in patients with Atherosclerotic cardiovascular disease (ASCVD). The primary endpoint is a composite of all-cause death, hospitalization for MI, or hospitalization for stroke. The primary safety endpoint is hospitalization for major bleeding with an associated blood product transfusion.

Study identification

NCT ID
NCT02697916
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Duke University
Other
Enrollment
15,076 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2016 (Actual)
Primary completion
Jun 30, 2020 (Actual)
Completion
Jun 30, 2020 (Actual)
Last update posted
Jul 1, 2021

2016 – 2020

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
31
Facility City State ZIP Site status
UCLA Medical Center Los Angeles California 90095 —
HealthCore Wilmington Delaware 19801 —
University of Florida Cardiology - Springhill Gainesville Florida 32606 —
Florida Hospital Orlando Florida 32806 —
Orlando Health Orlando Florida 32806 —
Bond Community Health Center Tallahassee Florida 32301 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
University of Chicago Medical Center Chicago Illinois 60637 —
Indiana University Indianapolis Indiana 46202 —
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Ochsner Health System New Orleans Louisiana 70112 —
Tulane University Heart & Vascular Institute New Orleans Louisiana 70112 —
Johns Hopkins Medical Center Baltimore Maryland 21287 —
University of Michigan Ann Arbor Michigan 48109 —
Essentia Health St. Mary's Medical Center Duluth Minnesota 55805 —
Allina Health Minneapolis Minnesota 55407 —
Mayo Clinic Rochester Minnesota 55905 —
University of Missouri Columbia Missouri 65211 —
University of Nebraska Medical Center Omaha Nebraska 68196 —
New York University School of Medicine New York New York 10016 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Weill Cornell Medicine of Cornell University New York New York 10065 —
Montefiore Medical Center New York New York 10461 —
UNC Chapel Hill Chapel Hill North Carolina 27514 —
Duke University Durham North Carolina 27701 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Ohio State Univerity Columbus Ohio 43210 —
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Vanderbilt University Nashville Tennessee 37203 —
Baylor Scott and White Heart and Vascular Hospital Dallas Texas 75226 —
University of Texas-Southwestern Dallas Texas 75390 —
University of Texas Health Sciences Center at San Antonio San Antonio Texas 78229 —
Intermountain Medical Center Salt Lake City Utah 84107 —
University of Utah Hospitals and Clinics Salt Lake City Utah 84112 —
Marshfield Clinic Marshfield Wisconsin 54449 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02697916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2021 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02697916 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →